top of page
PulseMedica Background Dots.jpeg
PulseMedica logo

A Vision Without Eye Disease

PulseMedica is developing a platform that is intended to be the first safe, effective, and non-invasive system to screen and treat vitreoretinal disease, starting with symptomatic vitreous opacities (eye floaters).

PulseMedica Close Up View 1 - Transparent Background (Web)_edited.png

Recent News

May 5, 2025

Developing Revolutionary Technology to Diagnose and Treat vitreoretinal Disease

Introducing the world’s first non-invasive, image-guided laser platform for eye floaters and posterior eye conditions.
Backed by Leading Investors
PulseMedica Platform Solution for Floaters 3 Web.jpg

Our Mission

PulseMedica is laser focused on improving the quality of life for millions of people by building revolutionary technology to image and treat vitreoretinal disease.

Millions Worldwide Suffering from Eye Disease

Conditions such as vitreous floaters, age-related macular degeneration (AMD), diabetic retinopathy, and vitreomacular traction affect hundreds of millions of people worldwide.

Eye Injection PulseMedica Web.jpg

The Impact of Eye Floaters

52% of adults have floaters, where 5-10% of those impacted experience severe impairments and have no safe and non-invasive treatment options.

  • Vision Impairments

  • Anxiety 

  • Stress

  • Depression

  • Reduced Quality of Life

Mild, moderate, and severe impairments from floaters.

The Need For  Floater Treatment

There is a significant unmet need for a safe, effective and non-invasive office-based device to screen, diagnose, and treat eye floaters.

PulseMedica Platform Solution for Floaters 2 Web.jpg

Platform Technology

High-Resolution Real Time Imaging
Enhanced Laser Accuracy & Safety
Automated Treatment & Planning

Image Guided Laser Treatment

PulseMedica-Floater ML Tracking Heatmap Clip-Web.gif

PulseMedica News and Updates

Latest developments, investments, and breakthroughs in our journey

May 5, 2025

Developing Revolutionary Technology to Diagnose and Treat vitreoretinal Disease

Introducing the world’s first non-invasive, image-guided laser platform for eye floaters and posterior eye conditions.

Edmonton Global

2025

How three Edmonton region innovators are redefining their industries with AI

Wealthsimple

2025

5 Canadian Companies to Watch

AMII

2024

AI Seminar: Applying ML Technologies to Screen and Treat Eye Floaters
More PulseMedica Updates and News Content
logo_final.png

PulseMedica is Hiring, Join Our Team!

New Opportunities:

Systems V&V Engineer
Electronics Design Team Lead
Sr. Optical Engineer

Meet Our Newest Team Members

We’re excited to introduce new team members helping shape the future of ophthalmology with bold ideas, technical excellence, and a shared commitment to impact.

John Tamkin

John Tamkin

Director of Optical Science Research and Development

Shubho Mohajan

Shubho Mohajan

Optics Technician

Vadim Elagin

Vadim Elagin

Sr. Software Developer

bottom of page